Back to company

SPECIFIC PHARMA A/S: Financial statements 2020

CVR: 33161395

SPECIFIC PHARMA A/S (CVR 33161395) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 128,248,000 and a net result of DKK 8,237,000 compared with DKK 8,914,000 the year before. That is a decrease of 12.4% compared with the year before. The profit margin was 6.4%. Equity amounted to DKK 80,199,000. The solvency ratio was 84.1%. The company had 16 employees in the financial year.

Revenue
128,248,000 kr.
Gross Profit
27,006,000 kr.
Profit/Loss
8,237,000 kr.
Equity
80,199,000 kr.
Total Assets
95,307,000 kr.
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020128.2 mio.27 mio.8.2 mio.80.2 mio.16
2019146.4 mio.25.3 mio.8.9 mio.78.6 mio.15
2018145.7 mio.29.7 mio.14.8 mio.69.7 mio.12
2017142.4 mio.41.9 mio.26.2 mio.74.6 mio.8
2016141.1 mio.-20.2 mio.63.5 mio.8

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is SPECIFIC PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Pia Rask Stewart joins the board of SPECIFIC PHARMA A/SDec 4, 2020

As of December 4, 2020, Pia Rask Stewart has joined the board of directors of SPECIFIC PHARMA A/S.

Per Bornhøft Hansen leaves the board of SPECIFIC PHARMA A/SDec 4, 2020

As of December 4, 2020, Per Bornhøft Hansen has left the board of directors of SPECIFIC PHARMA A/S.

About SPECIFIC PHARMA A/S

SPECIFIC PHARMA A/S is a Danish company of the type Aktieselskab based in København SV, founded in 2010. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Uffe Kåre Jensen. The company is owned by NOMECO A/S. The company has 24 employees. In 2026, the company reported revenue of DKK 157,797,000 and a net result of DKK 15,192,000 compared with DKK 29,239,000 the year before. Equity amounted to DKK 98,645,000.